Acquiring Company
Helus Pharma
Acquired Company
Small Pharma
TorontoOtherManufacturingBiotechnologyHealth CarePharmaceuticalBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, and Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) (“Small Pharma”), a U.K.-based biotechnology company focused on short-duration psychedelic therapies for mental health conditions, today announced that they have entered into a definitive arrangement agreement (the “Agreement”) pursuant to which Cybin will acquire all of Small Pharma’s issued and outstanding securities in an all-share transaction pursuant to a plan of arrangement (the “Transaction”).
Quick answer
Helus Pharma is acquiring Small Pharma, announced August 28, 2023. Helus Pharma is based in Toronto, Ontario, Canada.
- How much did Helus Pharma pay for Small Pharma?
- The deal value was not disclosed.
- What does Helus Pharma do?
- Helus Pharma is a mental health-focused biopharmaceutical company developing small-molecule Novel Serotonergic Agonists (NSAs) to improve treatment options.
- Where are Helus Pharma and Small Pharma based?
- Helus Pharma is based in Toronto, Ontario, Canada.
- Who are the decision-makers at Helus Pharma?
- Fundz holds 4 contacts at Helus Pharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Lilly To Acquire Versanis To Improve Patient Outcomes In Cardiometabolic Diseases (July 14, 2023)
- Lilly To Acquire Point Biopharma To Expand Oncology Capabilities Into Next-Generation Radioligand Therapies (October 3, 2023)
- Lilly Completes Acquisition Of Dice Therapeutics (August 9, 2023)
- Airlife Completes Acquisition Of Avanos Medical’S Respiratory Health Business (October 2, 2023)
- Regeneron Completes Acquisition Of Decibel Therapeutics, Adding Promising Gene Therapy Programs For Hearing Loss (September 25, 2023)
- Scilex Holding Company Announces The Consummation Of The Previously Announced Purchase Of All Of The Scilex Common Shares, Preferred Shares And Warrants Owned By Sorrento Therapeutics, Inc. (September 21, 2023)
Who to call at Helus Pharma, and when
When Helus Pharma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Helus Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Helus Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Helus Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Helus Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Small Pharma?
Small Pharma was acquired by Helus Pharma, based in Toronto. The deal was reported on August 28, 2023. Helus Pharma is a mental health-focused biopharmaceutical company developing small-molecule Novel Serotonergic Agonists (NSAs) to improve treatment options. Helus Pharma is publicly traded (HELP) and operates in Other.
When did Helus Pharma acquire Small Pharma?
Helus Pharma's acquisition of Small Pharma was reported on August 28, 2023. Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, and Small Pharma Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Small Pharma do?
Small Pharma is a biotechnology company progressing a pipeline of short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Small Pharma has a portfolio of clinical-stage DMT-based assets, SPL026 and SPL028. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.